tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market

AbCellera Biologics (ABCL) Income Statement

Compare
2,299 Followers

AbCellera Biologics Income Statement

Last quarter (Q4 2025), AbCellera Biologics's total revenue was $44.85M, an increase of 788.20% from the same quarter last year. In Q4, AbCellera Biologics's net income was $-8.95M. See AbCellera Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 75.13M$ 28.83M$ 38.02M$ 485.42M$ 375.20M
Gross Profit
$ 75.13M$ 28.83M$ 38.02M$ 418.99M$ 329.69M
Operating Expenses
$ 292.23M$ 343.60M$ 275.23M$ 202.48M$ 125.27M
Depreciation and Amortization
$ 22.17M$ 97.00M$ 30.89M$ 33.10M$ 17.25M
EBITDA
$ -155.42M$ -204.15M$ -192.16M$ 260.17M$ 239.15M
Operating Income
$ -217.10M$ -314.77M$ -237.21M$ 216.51M$ 204.41M
Other Income/Expenses
$ 39.51M$ 114.37M$ 63.18M$ 22.59M$ 14.74M
Pretax Income
$ -177.59M$ -200.40M$ -174.03M$ 239.10M$ 219.15M
Net Income
$ -146.41M$ -162.86M$ -146.40M$ 158.52M$ 153.46M
Per Share Metrics
Basic EPS
$ -0.49$ -0.55$ -0.51$ 0.56$ 0.56
Diluted EPS
$ -0.49$ -0.55$ -0.51$ 0.50$ 0.48
Weighted Average Shares Outstanding
298.71M 294.33M 289.17M 285.06M 275.76M
Weighted Average Shares Outstanding (Diluted)
298.71M 294.33M 289.17M 314.83M 318.29M
Currency in USD

AbCellera Biologics Earnings and Revenue History